ARCHIVES

Guideline Revisions or Outstanding Investigator Grant Still Controversial

This article is from The Cancer Letter archive.

Vol. 09 No. 47 | December 9, 1983

Download PDF Visit The Full Archive

Related Articles

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013

Mammography Panel Reaches Consensus On Most Issues

September 23, 1977

Rauscher Disappointed In CREG Progress

October 1, 1976

8 Pittsburg Employees Started Coalition That Lasted 8 Days

June 10, 1994

NCI Implementing Changes In Organ Site Program, Directing Grant applications To NIH Study Sections

October 15, 1982